Categories
Change Password!
Reset Password!
This prospective case–control study focused to examine the clinical utility of copeptin to assess the migraine attacks in patients admitted to the Emergency Department (ED).
Copeptin is a hypothalamic stress hormone
that functions as a prognostic marker in numerous acute disease conditions. As
observed from the study, the mean values of copeptin levels were not as reliable to be
deemed suitable for the determination of diagnostic efficacy in 52 migraine
patients under consideration.
This prospective case–control study focused to examine the clinical
utility of copeptin to assess the migraine attacks in patients admitted to the
Emergency Department (ED). The changes in serum copeptin levels in patients with
migraine during attack and without attack phases were also detected.
Fifty-two migraine patients and fifty-one healthy individuals with
similar demographic characteristics were included. The blood samples were
gathered from migraine patients during attack and without attack phases.
Mean copeptin levels of the patients in the attack and without
attack periods were found to be 689.28 and 576.68 pg/ml, correspondingly, while
these levels were 608.68 pg/ml in the control group. A significant difference
was observed in the mean copeptin level in the attack phase and without attack phases
(p = 0.026). Sensitivity and specificity of copeptin in identifying the headache
episodes in patients with migraine were 58.8% and 60.7%, at a cut-off value of
388.67 pg/ml.
As concluded, the diagnostic efficacy of serum copeptin
levels was found to be unacceptable for migranes, but it could be beneficial
for the management of migraine patients in the ED.
The American Journal of Emergency Medicine
Clinical use of copeptin in migraine patients admitted to the emergency department
Derya YalçınYılmaz et al.
Comments (0)